nodes	percent_of_prediction	percent_of_DWPC	metapath
Vapreotide—Nafarelin—Degarelix—prostate cancer	0.517	0.602	CrCrCtD
Vapreotide—Nafarelin—Goserelin—prostate cancer	0.343	0.398	CrCrCtD
Vapreotide—SSTR2—renal system—prostate cancer	0.00142	0.296	CbGeAlD
Vapreotide—TACR1—prostate gland—prostate cancer	0.00138	0.288	CbGeAlD
Vapreotide—TACR1—renal system—prostate cancer	0.000942	0.197	CbGeAlD
Vapreotide—TACR1—testis—prostate cancer	0.000609	0.127	CbGeAlD
Vapreotide—TACR1—lymph node—prostate cancer	0.000441	0.0921	CbGeAlD
Vapreotide—Octreotide—MPO—prostate cancer	0.000397	0.748	CrCbGaD
Vapreotide—Desmopressin—PTGS2—prostate cancer	0.000133	0.252	CrCbGaD
Vapreotide—SSTR5—Signaling Pathways—CASP9—prostate cancer	5.82e-05	0.000431	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—CXCL12—prostate cancer	5.71e-05	0.000423	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—PIK3CD—prostate cancer	5.7e-05	0.000422	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—PRKCQ—prostate cancer	5.64e-05	0.000418	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—NGFR—prostate cancer	5.64e-05	0.000418	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—MAP3K7—prostate cancer	5.57e-05	0.000413	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—PIK3CG—prostate cancer	5.43e-05	0.000403	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—CASP9—prostate cancer	5.37e-05	0.000398	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—FGF10—prostate cancer	5.36e-05	0.000397	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—ADRB2—prostate cancer	5.3e-05	0.000393	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—PIK3CD—prostate cancer	5.26e-05	0.00039	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—JAK2—prostate cancer	5.23e-05	0.000387	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—PTHLH—prostate cancer	5.22e-05	0.000387	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—TGFBR1—prostate cancer	5.22e-05	0.000387	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—MAP2K1—prostate cancer	5.21e-05	0.000386	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—PRKCQ—prostate cancer	5.21e-05	0.000386	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—NGFR—prostate cancer	5.21e-05	0.000386	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—PIK3CD—prostate cancer	5.18e-05	0.000383	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—VAV3—prostate cancer	5.17e-05	0.000383	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—MAP3K7—prostate cancer	5.14e-05	0.000381	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—AKR1C3—prostate cancer	5.14e-05	0.000381	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—PRKACB—prostate cancer	5.11e-05	0.000379	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—TGFBR2—prostate cancer	5.1e-05	0.000378	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—ITPR1—prostate cancer	5.02e-05	0.000372	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—THBS1—prostate cancer	4.98e-05	0.000369	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—PPP3CA—prostate cancer	4.98e-05	0.000369	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—PIK3CB—prostate cancer	4.97e-05	0.000368	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—FGF10—prostate cancer	4.95e-05	0.000366	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—ANXA1—prostate cancer	4.91e-05	0.000364	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—ADRB2—prostate cancer	4.89e-05	0.000363	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—JAK2—prostate cancer	4.83e-05	0.000358	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—PRKCZ—prostate cancer	4.82e-05	0.000357	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—MAP2K1—prostate cancer	4.81e-05	0.000356	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—IGF1R—prostate cancer	4.8e-05	0.000355	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—PIK3CD—prostate cancer	4.78e-05	0.000354	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—CXCL8—prostate cancer	4.78e-05	0.000354	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—VAV3—prostate cancer	4.77e-05	0.000354	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—JAK2—prostate cancer	4.75e-05	0.000352	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—PIK3CG—prostate cancer	4.71e-05	0.000349	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—TGFBR2—prostate cancer	4.7e-05	0.000348	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—FGFR4—prostate cancer	4.66e-05	0.000345	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—PARP1—prostate cancer	4.66e-05	0.000345	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—ITPR1—prostate cancer	4.63e-05	0.000343	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—LPL—prostate cancer	4.6e-05	0.000341	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CALCA—prostate cancer	4.6e-05	0.000341	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—PIK3CB—prostate cancer	4.59e-05	0.00034	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—IL2—prostate cancer	4.56e-05	0.000338	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—PDGFRB—prostate cancer	4.56e-05	0.000338	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—PIK3CB—prostate cancer	4.51e-05	0.000334	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CXCL12—prostate cancer	4.49e-05	0.000333	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—ITGB3—prostate cancer	4.44e-05	0.000329	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—IGF1R—prostate cancer	4.43e-05	0.000328	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—CXCL8—prostate cancer	4.41e-05	0.000326	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—JAK2—prostate cancer	4.38e-05	0.000325	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—CXCL8—prostate cancer	4.34e-05	0.000321	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—ERBB3—prostate cancer	4.31e-05	0.000319	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—FGFR2—prostate cancer	4.3e-05	0.000319	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—PIK3CG—prostate cancer	4.28e-05	0.000317	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—LPL—prostate cancer	4.24e-05	0.000314	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CASP9—prostate cancer	4.23e-05	0.000313	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—IL2—prostate cancer	4.21e-05	0.000312	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—PDGFRB—prostate cancer	4.21e-05	0.000312	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—PIK3CB—prostate cancer	4.16e-05	0.000308	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—IL2—prostate cancer	4.14e-05	0.000307	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—PIK3CD—prostate cancer	4.14e-05	0.000307	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—TERT—prostate cancer	4.13e-05	0.000306	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—NGFR—prostate cancer	4.1e-05	0.000304	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—PRKCQ—prostate cancer	4.1e-05	0.000304	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—ITGB3—prostate cancer	4.1e-05	0.000304	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—MAP3K7—prostate cancer	4.05e-05	0.0003	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—CXCL8—prostate cancer	4e-05	0.000296	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—ERBB3—prostate cancer	3.98e-05	0.000294	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—FGFR2—prostate cancer	3.97e-05	0.000294	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—HIF1A—prostate cancer	3.95e-05	0.000292	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—FGF10—prostate cancer	3.89e-05	0.000288	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—LEP—prostate cancer	3.85e-05	0.000285	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—ADRB2—prostate cancer	3.85e-05	0.000285	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—IL2—prostate cancer	3.82e-05	0.000283	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—CAV1—prostate cancer	3.82e-05	0.000283	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—TERT—prostate cancer	3.81e-05	0.000282	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—JAK2—prostate cancer	3.8e-05	0.000282	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—MAP2K1—prostate cancer	3.79e-05	0.00028	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—KDR—prostate cancer	3.78e-05	0.00028	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—PIK3CD—prostate cancer	3.76e-05	0.000279	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—VAV3—prostate cancer	3.76e-05	0.000278	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—TGFBR2—prostate cancer	3.7e-05	0.000274	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—ESR1—prostate cancer	3.68e-05	0.000273	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—ITPR1—prostate cancer	3.64e-05	0.00027	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—HIF1A—prostate cancer	3.64e-05	0.00027	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—PIK3CB—prostate cancer	3.61e-05	0.000267	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—BAD—prostate cancer	3.59e-05	0.000266	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—LEP—prostate cancer	3.56e-05	0.000263	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—CAV1—prostate cancer	3.52e-05	0.000261	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—KDR—prostate cancer	3.49e-05	0.000258	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—IGF1R—prostate cancer	3.49e-05	0.000258	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—APC—prostate cancer	3.48e-05	0.000258	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—PIK3CG—prostate cancer	3.48e-05	0.000258	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—CXCL8—prostate cancer	3.47e-05	0.000257	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—JAK2—prostate cancer	3.45e-05	0.000256	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—IRS1—prostate cancer	3.44e-05	0.000255	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—EGF—prostate cancer	3.44e-05	0.000255	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—ESR1—prostate cancer	3.4e-05	0.000252	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—LPL—prostate cancer	3.34e-05	0.000247	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—GSK3B—prostate cancer	3.34e-05	0.000247	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—IL2—prostate cancer	3.32e-05	0.000246	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—BAD—prostate cancer	3.31e-05	0.000246	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—PDGFRB—prostate cancer	3.31e-05	0.000245	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—INS—prostate cancer	3.29e-05	0.000244	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—PIK3CB—prostate cancer	3.28e-05	0.000243	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—ITGB3—prostate cancer	3.23e-05	0.000239	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—CREBBP—prostate cancer	3.23e-05	0.000239	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—APC—prostate cancer	3.21e-05	0.000238	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—PIK3CG—prostate cancer	3.21e-05	0.000238	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—IGF1—prostate cancer	3.19e-05	0.000236	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—EGF—prostate cancer	3.17e-05	0.000235	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—IRS1—prostate cancer	3.17e-05	0.000235	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—EGFR—prostate cancer	3.17e-05	0.000235	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—CXCL8—prostate cancer	3.15e-05	0.000233	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—ERBB3—prostate cancer	3.13e-05	0.000232	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—FGFR2—prostate cancer	3.13e-05	0.000231	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—GSK3B—prostate cancer	3.08e-05	0.000228	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—MAP2K1—prostate cancer	3.08e-05	0.000228	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—PIK3CD—prostate cancer	3.06e-05	0.000227	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—INS—prostate cancer	3.04e-05	0.000225	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—PIK3CA—prostate cancer	3.03e-05	0.000224	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—SERPINE1—prostate cancer	3.02e-05	0.000224	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—IL2—prostate cancer	3.01e-05	0.000223	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—TERT—prostate cancer	3e-05	0.000222	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—KRAS—prostate cancer	2.99e-05	0.000222	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—CREBBP—prostate cancer	2.98e-05	0.00022	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—IGF1—prostate cancer	2.94e-05	0.000218	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—FGF2—prostate cancer	2.93e-05	0.000217	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—EGFR—prostate cancer	2.92e-05	0.000217	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—NOS3—prostate cancer	2.89e-05	0.000214	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—HIF1A—prostate cancer	2.87e-05	0.000212	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—MAP2K1—prostate cancer	2.84e-05	0.00021	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—PIK3CD—prostate cancer	2.82e-05	0.000209	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—JAK2—prostate cancer	2.81e-05	0.000208	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—LEP—prostate cancer	2.8e-05	0.000207	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—PIK3CA—prostate cancer	2.8e-05	0.000207	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—SERPINE1—prostate cancer	2.79e-05	0.000207	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CAV1—prostate cancer	2.77e-05	0.000206	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—KRAS—prostate cancer	2.76e-05	0.000205	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—PIK3CA—prostate cancer	2.75e-05	0.000204	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—KDR—prostate cancer	2.74e-05	0.000203	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—MDM2—prostate cancer	2.74e-05	0.000203	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—FGF2—prostate cancer	2.7e-05	0.0002	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—ERBB2—prostate cancer	2.7e-05	0.0002	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—ESR1—prostate cancer	2.67e-05	0.000198	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—PIK3CB—prostate cancer	2.67e-05	0.000197	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—NOS3—prostate cancer	2.67e-05	0.000197	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—BAD—prostate cancer	2.61e-05	0.000193	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—JAK2—prostate cancer	2.59e-05	0.000192	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—CXCL8—prostate cancer	2.56e-05	0.00019	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—PIK3CA—prostate cancer	2.54e-05	0.000188	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—MDM2—prostate cancer	2.53e-05	0.000187	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—PIK3CG—prostate cancer	2.53e-05	0.000187	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—APC—prostate cancer	2.53e-05	0.000187	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—CDKN1B—prostate cancer	2.5e-05	0.000185	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—EGF—prostate cancer	2.5e-05	0.000185	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—IRS1—prostate cancer	2.5e-05	0.000185	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—ERBB2—prostate cancer	2.49e-05	0.000185	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—AKT1—prostate cancer	2.47e-05	0.000183	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—PIK3CB—prostate cancer	2.46e-05	0.000182	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—CASP3—prostate cancer	2.45e-05	0.000182	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—IL2—prostate cancer	2.45e-05	0.000181	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—IL6—prostate cancer	2.44e-05	0.00018	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—GSK3B—prostate cancer	2.43e-05	0.00018	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—INS—prostate cancer	2.39e-05	0.000177	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—CCND1—prostate cancer	2.39e-05	0.000177	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—CXCL8—prostate cancer	2.36e-05	0.000175	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—CTNNB1—prostate cancer	2.36e-05	0.000175	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CREBBP—prostate cancer	2.34e-05	0.000174	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—MMP9—prostate cancer	2.32e-05	0.000172	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—IGF1—prostate cancer	2.31e-05	0.000171	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—CDKN1A—prostate cancer	2.31e-05	0.000171	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—CDKN1B—prostate cancer	2.31e-05	0.000171	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—PTEN—prostate cancer	2.3e-05	0.000171	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—EGFR—prostate cancer	2.3e-05	0.000171	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—AKT1—prostate cancer	2.28e-05	0.000169	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—CASP3—prostate cancer	2.26e-05	0.000168	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—IL2—prostate cancer	2.26e-05	0.000167	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—IL6—prostate cancer	2.25e-05	0.000166	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—AKT1—prostate cancer	2.25e-05	0.000166	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—MAP2K1—prostate cancer	2.24e-05	0.000166	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—PIK3CD—prostate cancer	2.22e-05	0.000165	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—CCND1—prostate cancer	2.2e-05	0.000163	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—PIK3CA—prostate cancer	2.2e-05	0.000163	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—SERPINE1—prostate cancer	2.2e-05	0.000163	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—EP300—prostate cancer	2.2e-05	0.000163	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—CTNNB1—prostate cancer	2.18e-05	0.000162	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—KRAS—prostate cancer	2.18e-05	0.000161	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—MMP9—prostate cancer	2.14e-05	0.000158	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—SRC—prostate cancer	2.14e-05	0.000158	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—CDKN1A—prostate cancer	2.13e-05	0.000158	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—FGF2—prostate cancer	2.13e-05	0.000158	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—PTEN—prostate cancer	2.13e-05	0.000157	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—NOS3—prostate cancer	2.1e-05	0.000155	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—VEGFA—prostate cancer	2.08e-05	0.000154	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—AKT1—prostate cancer	2.07e-05	0.000154	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—STAT3—prostate cancer	2.06e-05	0.000153	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—JAK2—prostate cancer	2.04e-05	0.000151	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—EP300—prostate cancer	2.03e-05	0.00015	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—PIK3CA—prostate cancer	2e-05	0.000148	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—MDM2—prostate cancer	1.99e-05	0.000147	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—SRC—prostate cancer	1.97e-05	0.000146	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—ERBB2—prostate cancer	1.96e-05	0.000145	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—PIK3CB—prostate cancer	1.94e-05	0.000143	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—VEGFA—prostate cancer	1.92e-05	0.000142	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—MYC—prostate cancer	1.91e-05	0.000142	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—TGFB1—prostate cancer	1.91e-05	0.000141	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—STAT3—prostate cancer	1.9e-05	0.000141	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—EGFR—prostate cancer	1.87e-05	0.000139	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CXCL8—prostate cancer	1.86e-05	0.000138	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CDKN1B—prostate cancer	1.82e-05	0.000135	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—AKT1—prostate cancer	1.8e-05	0.000133	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CASP3—prostate cancer	1.78e-05	0.000132	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—IL2—prostate cancer	1.78e-05	0.000132	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—IL6—prostate cancer	1.77e-05	0.000131	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—KRAS—prostate cancer	1.77e-05	0.000131	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—MYC—prostate cancer	1.77e-05	0.000131	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—TGFB1—prostate cancer	1.76e-05	0.000131	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CCND1—prostate cancer	1.73e-05	0.000128	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—EGFR—prostate cancer	1.73e-05	0.000128	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CTNNB1—prostate cancer	1.72e-05	0.000127	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—MMP9—prostate cancer	1.68e-05	0.000125	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CDKN1A—prostate cancer	1.68e-05	0.000124	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—PTEN—prostate cancer	1.67e-05	0.000124	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—AKT1—prostate cancer	1.63e-05	0.000121	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—KRAS—prostate cancer	1.63e-05	0.000121	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—PIK3CA—prostate cancer	1.62e-05	0.00012	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—EP300—prostate cancer	1.6e-05	0.000118	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—TP53—prostate cancer	1.57e-05	0.000116	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—SRC—prostate cancer	1.55e-05	0.000115	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—VEGFA—prostate cancer	1.51e-05	0.000112	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—PIK3CA—prostate cancer	1.5e-05	0.000111	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—STAT3—prostate cancer	1.5e-05	0.000111	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—TP53—prostate cancer	1.45e-05	0.000107	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—IL6—prostate cancer	1.44e-05	0.000107	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—MYC—prostate cancer	1.39e-05	0.000103	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—TGFB1—prostate cancer	1.39e-05	0.000103	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—EGFR—prostate cancer	1.36e-05	0.000101	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—IL6—prostate cancer	1.33e-05	9.84e-05	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—AKT1—prostate cancer	1.33e-05	9.83e-05	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—KRAS—prostate cancer	1.29e-05	9.52e-05	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—AKT1—prostate cancer	1.23e-05	9.07e-05	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—PIK3CA—prostate cancer	1.18e-05	8.74e-05	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—TP53—prostate cancer	1.14e-05	8.46e-05	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—IL6—prostate cancer	1.05e-05	7.74e-05	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—AKT1—prostate cancer	9.65e-06	7.14e-05	CbGpPWpGaD
